Australia Platelet Rich Plasma (prp) Market Size & Outlook

The platelet rich plasma (prp) market in Australia is expected to reach a projected revenue of US$ 17.6 million by 2030. A compound annual growth rate of 16.1% is expected of Australia platelet rich plasma (prp) market from 2024 to 2030.
Revenue, 2023 (US$M)
$6.2
Forecast, 2030 (US$M)
$17.6
CAGR, 2024 - 2030
16.1%
Report Coverage
Australia

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Australia platelet rich plasma (prp) market, 2018-2030 (US$M)

Australia platelet rich plasma (prp) market, 2018-2030 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Australia platelet rich plasma (prp) market highlights

  • The Australia platelet rich plasma (prp) market generated a revenue of USD 6.2 million in 2023 and is expected to reach USD 17.6 million by 2030.
  • The Australia market is expected to grow at a CAGR of 16.1% from 2024 to 2030.
  • In terms of segment, pure prp was the largest revenue generating type in 2023.
  • Leukocyte Rich PRP is the most lucrative type segment registering the fastest growth during the forecast period.


Platelet rich plasma (prp) market data book summary

Market revenue in 2023USD 6.2 million
Market revenue in 2030USD 17.6 million
Growth rate16.1% (CAGR from 2023 to 2030)
Largest segmentPure prp
Fastest growing segmentLeukocyte Rich PRP
Historical data2018 - 2022
Base year2023
Forecast period2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationPure PRP, Leukocyte Rich PRP
Key market players worldwideJohnson & Johnson, Arthrex, Terumo Corp, Zimmer Biomet Holdings Inc, Stryker Corp, EmCyte Corporation, Dr. PRP USA, Juventix Regenerative Medical, APEX Biologix, Celling Biosciences


Other key industry trends

  • In terms of revenue, Australia accounted for 1.0% of the global platelet rich plasma (prp) market in 2023.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Asia Pacific, India platelet rich plasma (prp) market is projected to lead the regional market in terms of revenue in 2030.
  • Japan is the fastest growing regional market in Asia Pacific and is projected to reach USD 90.7 million by 2030.

Pure prp was the largest segment with a revenue share of 46.77% in 2023. Horizon Databook has segmented the Australia platelet rich plasma (prp) market based on pure prp, leukocyte rich prp covering the revenue growth of each sub-segment from 2018 to 2030.


PRP has emerged as a promising treatment in regenerative medicine in Australia. Clinics and healthcare providers have praised its benefits, often featuring celebrity endorsements, suggesting that PRP can address various issues, such as chronic pain, hair loss, and wrinkles.

Osteoarthritis, a leading cause of pain and disability in Australia affecting approximately 2 million people, has prompted significant interest in treatments that can alleviate symptoms and potentially slow or reverse disease progression.

A clinical trial conducted by the University of Melbourne demonstrated significant improvement in knee pain over 12 months among those who received PRP injections. In addition, Australian Sports Doctors (ASD) offer PRP injections as part of their services in Melbourne, focusing on assessing and managing musculoskeletal conditions and sports injuries.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Platelet Rich Plasma (PRP) Market Companies

Name Profile # Employees HQ Website
Celling Biosciences View profile - -
APEX Biologix View profile 11-50 Murray, Utah, United States, North America https://apexbiologix.com
Juventix Regenerative Medical View profile 11-50 Tampa, Florida, United States, North America https://juventix.com/
Dr. PRP USA View profile 11-50 Stafford, Texas, United States, North America https://www.drprpusa.com
EmCyte Corporation View profile 11-50 Fort Myers, Florida, United States, North America https://emcyte.com/
Arthrex View profile 5001-10000 Naples, Florida, United States, North America https://www.arthrex.com/
Terumo Corp View profile 30207 2-44-1 Hatagaya, Shibuya-ku, Tokyo, Japan, 151-0072 https://www.terumo.com
Zimmer Biomet Holdings Inc View profile 18000 345 East Main Street, Warsaw, IN, United States, 46580 https://www.zimmerbiomet.com
Stryker Corp View profile 52000 1941 Stryker Way, Portage, MI, United States, 49002 https://www.stryker.com
Johnson & Johnson View profile 134400 One Johnson and Johnson Plaza, New Brunswick, NJ, United States, 08933 https://www.jnj.com

Australia platelet rich plasma (prp) market size, by type, 2018-2030 (US$M)

Australia Platelet Rich Plasma (PRP) Market Outlook Share, 2023 & 2030 (US$M)

Australia platelet rich plasma (prp) market size, by type, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online